FindTrial
Sign In

Effects of oxycodone for transvaginal oocyte retrieval and patients' postoperative immune function

Effects of oxycodone for transvaginal oocyte retrieval and patients' postoperative immune function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056080
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-01-27
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painless transvaginal oocyte retrieval

Interventions

Group 1:oxycodone 0.1 mg/kg
Group 2:fentanyl 1 ug/kg

Sponsors

Wuxi Maternal and Child Health Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Age 20-40 years; 2.Female; 3.BMI 18.5-24; 4.ASA class I-II.

Exclusion criteria

Exclusion criteria: 1.History of sedative and analgesic addiction; 2.History of respiratory and cardiovascular diseases or liver and kidney dysfunction; 3.Expected to have difficult airway; 4.With acute and chronic pain pre-operation.

Design outcomes

Primary

MeasureTime frame
CD4+%;CD8+%;CD4/CD8;—

Secondary

MeasureTime frame
Numeric Rating Scale, NRS;Hemodynamic index;Total dosage of anesthetics;Intraoperative adverse events;—

Countries

China

Contacts

Public ContactShen Mingkun

Wuxi Maternal and Child Health Hospital Affiliated to Nanjing Medical University

wxfy2042@163.com+86 510 81910790

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026